Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AsymBio has begun construction of a new R&D building at its Shanghai Fengxian site, a move the company said will strengthen its biologics CDMO capabilities and support a full-lifecycle, one-stop service ecosystem.
read more
Piramal Pharma said it began FY27 with stronger revenue and margin expansion, driven by broad-based growth across its contract development and manufacturing, complex hospital generics and consumer healthcare businesses.
read more
Cellipont Bioservices announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas.
read more
Polpharma Biologics announced that the FDA and the EMA have accepted for review the Biologics License Application (BLA) and Marketing Authorization Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s ...
read more
Codis has completed its acquisition of Catalent’s Nottingham, UK facility, a move that expands the company’s integrated spray dry offering in Europe and adds oral solid dose development and small-scale commercial manufacturing capabilities.
read more
Genezen and the Raiden Science Foundation have announced a manufacturing partnership for an AAV9 gene replacement therapy for UBA5 disorder, moving the program closer to a first-in-human clinical trial.
read more
Resilience announced it has expanded its strategic partnership with Eli Lilly and Company to increase U.S. production of critical medicines featuring new pharmaceutical manufacturing investments in Ohio.
read more
Piramal Pharma Solutions has expanded its peptide API facility in Turbhe, India, with a new spray drying suite designed to support challenging formulations for peptides, HPAPIs and other biomolecules.
read more
Wednesday, August 05, 2026
Porton Advanced Solutions has secured a Drug Manufacturing License (Class C) from China’s National Medical Products Administration, a milestone that allows the company to undertake commercial contract manufacturing for cell and gene therapy products.
read more
Wednesday, August 05, 2026
Clinilabs has appointed Bob Dagher, M.D., as chief medical officer and Waqar Ahmed Siddiqui, M.D., as principal investigator at its Eatontown, New Jersey clinical research unit.
read more
Wednesday, August 05, 2026
Altruist Biologics has completed the first commercial process performance qualification campaign for its 20,000L stainless steel bioreactors at its Hangzhou site, marking successful commercial-scale completion of three consecutive batches.
read more
Thursday, August 06, 2026
Altasciences has completed an expansion of the research and development laboratory at its drug product formulation and manufacturing facility in Harleysville, Pennsylvania, adding about 768 square feet of new lab space.
read more